Not recruiting
Registered drug
Study on the Effects of Atacicept in Adults with IgA Nephropathy
Registered drug
Countries:
Greece
Greece- Participants:18–64 years · 65+ years
- Substances:Atacicept
- Sponsor:Vera Therapeutics Inc.
Back to GreeceClinical trials in Piraeus – page 11
128 clinical trials in Piraeus, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Piraeus at a glance
128
clinical trials
- Paediatric trials0
- Research sites1
Not recruiting
Malignant melanoma
Not recruitingRegistered drug
Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma
Registered drug
- Disease:Malignant melanoma
- Substances:Nivolumab
Countries:Greece
Greece- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Nivolumab
- Sponsor:Bristol-Myers Squibb Services Unlimited Company
Not recruiting
Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure
Not recruitingRegistered drugNo placebo
Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure
Registered drugNo placebo
- Substances:RisankizumabUstekinumab
Countries:Greece
Greece- Participants:18–64 years · 65+ years
- Substances:Risankizumab
- Sponsor:AbbVie Deutschland GmbH & Co. KG
Not recruiting
Non-small cell lung cancer
Not recruitingRegistered drugNo placebo
Study Comparing Pembrolizumab and Lenvatinib with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments
Registered drugNo placebo
- Disease:Non-small cell lung cancer
- Substances:LenvatinibPembrolizumab
Countries:Greece
Greece- Participants:18–64 years · 65+ years
- Substances:Lenvatinib
- Sponsor:Merck Sharp & Dohme LLC
Not recruiting
Small cell lung cancer
Not recruitingRegistered drug
Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer
Registered drug
- Disease:Small cell lung cancer
- Substances:AtezolizumabCarboplatin+4
Countries:Greece
Greece- Participants:18–64 years · 65+ years
- Substances:Atezolizumab
- Sponsor:Merck Sharp & Dohme LLC
Not recruiting
Non-small cell lung cancer
Not recruitingRegistered drug
Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer
Registered drug
- Disease:Non-small cell lung cancer
- Substances:DostarlimabPembrolizumab+1
Countries:Greece
Greece- Participants:18–64 years · 65+ years
- Substances:Dostarlimab
- Sponsor:Glaxosmithkline Research & Development Limited
Not recruiting
Non-small cell lung cancer
Not recruitingRegistered drugNo placebo
Study on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors
Registered drugNo placebo
- Disease:Non-small cell lung cancer
- Substances:CarboplatinInfliximab+5
Countries:Greece
Greece- Participants:18–64 years · 65+ years
- Substances:Carboplatin
- Sponsor:AstraZeneca AB
Not recruiting
Non-small cell lung cancer
Not recruitingRegistered drugNo placebo
Study on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment
Registered drugNo placebo
- Disease:Non-small cell lung cancer
- Substances:CarboplatinCisplatin+3
Countries:Greece
Greece- Participants:18–64 years · 65+ years
- Substances:Carboplatin
- Sponsor:AstraZeneca AB
Other cities in Greece
The busiest research cities in the country
Clinical research in Piraeus
What the registry says about research in the country
01 Oncology Research
Advanced clinical trials focusing on various cancer treatments, particularly in non-small cell lung cancer and novel therapeutic combinations. Studies include investigations of targeted therapies and immunotherapy approaches.
- Lung Cancer Therapies
- Melanoma Treatments
- Renal Cell Carcinoma
Innovative research combining standard treatments with new therapeutic agents to improve patient outcomes.
02 Cardiovascular Studies
Research initiatives targeting heart failure prevention and stroke prevention in patients with atrial fibrillation. Studies evaluate new therapeutic approaches for managing cardiovascular risks.
- Heart Failure Prevention
- Stroke Prevention
- Hypertension Management
Trials focusing on both preventive measures and treatment of established cardiovascular conditions.
03 Hematology Research
Clinical investigations in multiple myeloma and related blood disorders, exploring combination therapies and novel treatment approaches for patients with various blood-related conditions.
- Multiple Myeloma
- Plasma Cell Leukemia
- Blood Disorders
Studies examining innovative therapeutic combinations for improved patient outcomes.
04 Inflammatory Conditions
Research focusing on treating Crohn's Disease and other inflammatory conditions, evaluating new therapeutic options and combination treatments for better disease management.
- Gastrointestinal Disorders
- Autoimmune Conditions
- Novel Therapies
Studies aimed at improving treatment outcomes in chronic inflammatory diseases.